19th May 2015 13:15
UK stocks edged higher on Tuesday, despite confirmation of the UK's first deflation since the 1960s. Sector-wise, losses made by miners and telecommunications were offset by strong results from real estate, construction and insurance stocks. As of 2:30GMT, the FTSE 250 was trading 134 points higher
Read more19th May 2015 11:33
Despite confirmation of the UK's first deflation since the 1960s, London's blue chip shares passed midday on Tuesday in continuing positive territory. UK inflation fell 0.1% in the year to April, the first annual fall in the consumer prices index since the 1960s. Data from the Office for National S
Read more19th May 2015 10:49
Healthcare company BTG reported a drop in pre-tax annual profit, reflecting investments, acquisitions and foreign exchange movements. Pre-tax profit came to £26.7m, down from £33.3m the previous year, the group said. Revenue rose 27% to £367.8m from £290.5m a year earlier, as each division delivere
Read more2nd Apr 2015 23:49
Tate&Lyle surprised investors with its full-year pre-tax profit guidance. However, while management has drawn a line under a horrendous 2014 it has a lot of hard work ahead to shore-up investor confidence. The outfit now expects profits of between £230 to £245m, which is "modestly" lower than previo
Read more2nd Apr 2015 14:55
Drugs group BTG topped the risers after raising sales forecasts for the year, partly thanks to the acquisition of lung device company PneumRx. Food wholesale retailer Booker also rose after saying it had a "good end to a good year" with a 1% rise in fourth-quarter sales despite ongoing price deflati
Read more2nd Apr 2015 08:51
Healthcare group BTG said it expected annual revenue to be "slightly" higher than indicated earlier this year. The FTSE 250 group said expected revenue for the year ended 31 March would be above the previous guidance it provided of £345m to £360m, including revenue from the PneumRx acquisition it co
Read more1st Apr 2015 10:59
Healthcare company BTG said it started selling its drug-eluting bead and embolisation products to customers in 11 European countries. The products, DC Bead and Bead Block, will be sold directly to hospitals in Austria, Belgium, France, Germany, Ireland, Italy, Netherlands, Portugal, Switzerland, Spa
Read more5th Feb 2015 15:33
After currencies moved in its favour and the completion of a recent acquisition, healthcare group BTG has raised its guidance for full-year revenue. Full-year revenue is now expected to range between £345m and £360m, around 4% higher than the previous guidance of £330m to £345m. The FTSE 250 group
Read more8th Jan 2015 10:04
Specialist healthcare company BTG said it had completed its acquisition of US interventional pulmonology business PneumRx, which will cost the FTSE 250 group up to £315m. The acquisition had been conditional on the expiration or early termination of a waiting period under the Hart-Scott-Rodino Act i
Read more9th Dec 2014 09:23
Aberdeen: Cantor Fitzgerald initiates with a target price of 520p and a 'buy' recommendation. Aggreko: Jefferies reduces target price from 1810p to 1350p, downgrading to 'underperform'. Ashcourt Rowan: Cantor Fitzgerald initiates with a target price of 270p and a 'buy' recommendation. Ashmore: Can
Read more5th Dec 2014 11:55
Specialist packaging manufacturer DS Smith has proven adept at growing with its clients, acquiring rivals and moving into new niches and geographies. That has seen the company transformed from a maker of paper into a manufacturer of higher-margin specialist packaging. A case in point is the recent a
Read more5th Dec 2014 09:48
Amino Technologies: N`+1 Singer ups target price from 107p to 141p and keeps a 'buy' recommendation. Barr (AG): Numis upgrades from 'hold' to 'add' with a target price of 659p. Jefferies reduces target price from 678p to 510p and downgrades to 'sell'. Betfair: JP Morgan increases target price from
Read more4th Dec 2014 07:44
Healthcare group BTG has entered an agreement to acquire California-based PneumRx for £147m. The company said the purchase will be partly funded by a placing of new ordinary shares to raise approximately £150m, which represents 5% of the group's market capitalisation based on Wednesday's closing pri
Read more12th Nov 2014 09:07
Aberdeen: UBS lowers target price from 465p to 450p and downgrades from buy to neutral. ASOS: Societe Generale reduces target price from 5000p to 4450p, while leaving its buy recommendation unchanged. BG Group: Deutsche Bank reduces target price from 1400p to 1300p and keeps a buy recommendation.
Read more21st Oct 2014 14:38
Retail stocks were putting in a strong performance on Tuesday after data from BRC-Springboard showed the decline in UK retail footfall eased to 0.9% in September from a 1.1% drop in August. Stocks such as Debenhams, Home Retail, Just Eat, WH Smith and Halfords were all in positive territory. "With a
Read more